What happens when you stop taking a GLP-1 medication? This is one of the most important — and most anxiety-inducing — questions patients ask. The answer, based on clinical trial data and real-world evidence, is straightforward: most people regain a significant portion of the weight they lost. But there's more to the story than that.
What the Trials Show
The most direct evidence comes from the STEP 1 extension study. Participants who took Wegovy (semaglutide 2.4 mg) for 68 weeks lost an average of about 17% of their body weight. Those who then stopped the medication and were followed for an additional year regained approximately two-thirds of the weight they had lost. By one year off the drug, most participants had returned to about 5–6% below their starting weight — meaningful, but far less than the peak weight loss they'd achieved.
The SURMOUNT-4 trial for tirzepatide (Zepbound/Mounjaro) showed a similar pattern. Participants who were switched from tirzepatide to placebo after 36 weeks of treatment regained about half of the weight they'd lost over the following year, while those who continued treatment maintained or continued losing weight.
Why Weight Comes Back
This isn't a failure of willpower. It's biology. GLP-1 medications work by suppressing appetite, slowing gastric emptying, and influencing the brain's hunger signals. When you stop the medication, those effects stop too. Your appetite returns to its pre-treatment baseline, food noise comes back, and your body's set point mechanisms push toward weight regain.
Additionally, weight loss itself triggers metabolic adaptation — your body burns fewer calories at rest when it weighs less. This adaptation persists even after weight regain, creating a metabolic environment that favors continued weight gain. This is not unique to GLP-1 medications; it happens with any form of significant weight loss, including bariatric surgery and aggressive dieting.
Does This Mean You Have to Take Them Forever?
Current medical guidelines treat obesity as a chronic disease that requires ongoing management — similar to hypertension or type 2 diabetes. Just as you wouldn't expect your blood pressure to stay low after stopping blood pressure medication, you shouldn't expect weight to stay low after stopping weight loss medication.
That said, "forever" doesn't necessarily mean "the same dose forever." Some patients may successfully step down to a lower maintenance dose. Others may transition from injectable to oral formulations. And some patients who have made significant lifestyle changes — building regular exercise habits, establishing consistent protein intake, developing better sleep and stress management — may retain more of their weight loss after stopping than average. These are individual decisions made with your prescriber.
What You Can Control
If you're considering stopping GLP-1 medication — whether due to cost, side effects, or personal preference — there are strategies that may help mitigate weight regain. Maintain or increase resistance training to preserve metabolic rate. Keep protein intake high (at least 1.0–1.2 g/kg body weight daily). Establish these habits while still on the medication, so they're automatic by the time you stop. Work with your prescriber on a gradual tapering plan rather than abrupt discontinuation. And set realistic expectations: maintaining some of your weight loss is a better goal than maintaining all of it.
The Bottom Line
Most people regain weight after stopping GLP-1 medications — typically about two-thirds of what they lost within a year. This reflects the chronic nature of obesity, not a personal failure. The medications work as long as you take them, much like blood pressure or cholesterol medication.
If you stop, expect your appetite and food noise to return. Exercise, protein, and lifestyle habits built during treatment can help buffer against full regain. Talk to your prescriber about whether continuing treatment, reducing dose, or switching medications makes more sense than stopping entirely.